Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
DOI: 10.1016/j.ymthe.2022.05.013
Read
about Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
Pardi et al. (2022) “Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses” Nature Communications.
DOI: 10.1038/s41467-022-32149-8
Read
about Pardi et al. (2022) “Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses” Nature Communications.
Mu et al. (2022) “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice” Cell Reports.
DOI: 10.1016/j.celrep.2022.110514
Read
about Mu et al. (2022) “mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice” Cell Reports.
Rurik et al. (2022) “CAR T cells produced in vivo to treat cardiac injury” Science.
DOI: 10.1126/science.abm0594
Read
about Rurik et al. (2022) “CAR T cells produced in vivo to treat cardiac injury” Science.
Mallory et al. (2021) “Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice” NPJ Vaccines.
DOI: 10.1038/s41541-021-00345-0
Read
about Mallory et al. (2021) “Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice” NPJ Vaccines.
Musunuru et al. (2021) “In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates” Nature.
DOI:10.1038/s41586-021-03534-y
Read
about Musunuru et al. (2021) “In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates” Nature.
Rothgangl et al. (2021) “In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels” Nature Biotechnology.
DOI:10.1038/s41587-021-00933-4
Read
about Rothgangl et al. (2021) “In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels” Nature Biotechnology.
Rizvi et al. (2021) “Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA” Nature Communications.
DOI:10.1038/s41467-021-20903-3
Read
about Rizvi et al. (2021) “Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA” Nature Communications.
Villiger et al. (2021) “In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA” Nature Biomedical Engineering.
DOI:10.1038/s41551-020-00671-z
Read
about Villiger et al. (2021) “In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA” Nature Biomedical Engineering.
Weissman et al. (2021) “D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization” Cell Host & Microbe.
DOI:10.1016/j.chom.2020.11.012
Read
about Weissman et al. (2021) “D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization” Cell Host & Microbe.
Lederer et al. (2020) “SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation” Immunity.
DOI:10.1016/j.immuni.2020.11.009
Read
about Lederer et al. (2020) “SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation” Immunity.
Laczkó et al. (2020) “A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice” Immunity.
DOI:10.1016/j.immuni.2020.07.019
Read
about Laczkó et al. (2020) “A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice” Immunity.